Hybrid PET/CT for Noninvasive Pharmacokinetic Evaluation of Dynamic PolyConjugates, a Synthetic siRNA Delivery System

详细信息    查看全文

• 作者：Sarah R. Mudd ; Vladimir S. Trubetskoy ; Andrei V. Blokhin ; Jamey P. Weichert ; Jon A. Wolff
• 刊名：Bioconjugate Chemistry
• 出版年：2010
• 出版时间：July 21, 2010
• 年：2010
• 卷：21
• 期：7
• 页码：1183-1189
• 全文大小：324K
• 年卷期：v.21,no.7(July 21, 2010)
• ISSN：1520-4812

文摘

Positron emission tomography/computed tomography (PET/CT) hybrid imaging can be used to gain insights into a synthetic siRNA delivery system targeted to the liver. Either siRNA or the delivery vehicle was labeled with p>64p>Cu via 1, 4, 7, 10- tetraazacyclododecane- 1, 4, 7, 10- tetraacetic acid (DOTA) chelation. This study confirmed that the siRNA delivery system was successfully targeted to the liver. Incorporation of the siRNA into the delivery system protected the siRNA from renal filtration long enough so that the siRNA could be delivered to the liver. PET/CT imaging was important for confirming biodistribution and for determining differences in the distribution of labeled siRNA, siRNA incorporated into the delivery system, and the delivery system without siRNA.